TSPAN1 and breast cancer: Through Immunoblot, we found that downregulation of TSPAN1 inhibited the phosphorylation levels of PI3K and AKT, suggesting that TSPAN1 mediated the PI3K/AKT pathway in breast cancer cells (Figure 3b).